Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C: Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006, 60 (7): 762-769.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM: Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010, 95 (6): 2536-2559. 10.1210/jc.2009-2354.
Article
CAS
PubMed
Google Scholar
Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR: Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001, 86 (2): 724-731. 10.1210/jc.86.2.724.
Article
CAS
PubMed
Google Scholar
Guay AT: The emerging link between hypogonadism and metabolic syndrome. J Andol. 2009, 30 (4): 370-376. 10.2164/jandrol.108.006015.
Article
CAS
Google Scholar
National Cholesterol Education Program, National Institutes of Health: Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106 (25): 3143-3421.
Google Scholar
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112 (17): 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.
Article
PubMed
Google Scholar
Grundy SM, Hansen B, Smith SC, Cleeman JI, Kahn RA: Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation. 2004, 109 (4): 551-556. 10.1161/01.CIR.0000112379.88385.67.
Article
PubMed
Google Scholar
Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT: Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care. 2004, 27 (5): 1036-1041. 10.2337/diacare.27.5.1036.
Article
CAS
PubMed
Google Scholar
Ding EL, Song Y, Malik VS, Liu S: Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006, 295 (11): 1288-1299. 10.1001/jama.295.11.1288.
Article
CAS
PubMed
Google Scholar
Zitzmann M: Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol. 2009, 5 (12): 673-681. 10.1038/nrendo.2009.212.
Article
CAS
PubMed
Google Scholar
Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N: Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab. 2000, 85 (8): 2839-2853. 10.1210/jc.85.8.2839.
CAS
PubMed
Google Scholar
Kapoor D, Goodwin E, Channer KS, Jones TH: Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2006, 154 (6): 899-906. 10.1530/eje.1.02166.
Article
CAS
PubMed
Google Scholar
Kapoor D, Clarke S, Stanworth R, Channer KS, Jones TH: The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2007, 156 (5): 595-602. 10.1530/EJE-06-0737.
Article
CAS
PubMed
Google Scholar
Heufelder AE, Saad F, Bunck MC, Gooren L: Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. J Andol. 2009, 30 (6): 726-733. 10.2164/jandrol.108.007005.
Article
CAS
Google Scholar
Aversa A, Bruzziches R, Francomano D, Spera G: Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome. J Endocrinol Invest. 2010, 33 (11): 776-783.
Article
CAS
PubMed
Google Scholar
Aversa A, Bruzziches R, Francomano D, Rosano G, Isidori AM, Lenzi A, Spera G: Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study. J Sex Med. 2010, 7 (10): 3495-3503. 10.1111/j.1743-6109.2010.01931.x.
Article
CAS
PubMed
Google Scholar
Jones TH, Arver S, Behre HM, Buvat J, Meuleman E, Moncada I, Morales AM, Volterrani M, Yellowlees A, Howell JD, Channer KS: Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care. 2011, 34: 828-837. 10.2337/dc10-1233.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kalinchenko SY, Tishova YA, Mskhalaya GJ, Gooren LJ, Giltay EJ, Saad F: Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blind placebo-controlled Moscow study. Clin Endocrinol (Oxf). 2010, 73 (5): 602-612. 10.1111/j.1365-2265.2010.03845.x.
Article
CAS
Google Scholar
Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, Saad F, Lenzi A, Forti G, Mannucci E, Maggi M: Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med. 2011, 8 (1): 272-283. 10.1111/j.1743-6109.2010.01991.x.
Article
CAS
PubMed
Google Scholar
Miner MM, Khera M, Bhattacharya R, Blick G, Kushner H: Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency. Postgrad Med. 2011, 123 (3): 17-27.
Article
PubMed
Google Scholar
Traish AM, Guay A, Feeley R, Saad F: The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. J Andol. 2009, 30 (1): 10-22.
Article
CAS
Google Scholar
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120 (16): 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.
Article
CAS
PubMed
Google Scholar
Muller M, Grobbee DE, den Tonkelaar I, Lamberts SW, van der Schouw YT: Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab. 2005, 90 (5): 2618-2623. 10.1210/jc.2004-1158.
Article
CAS
PubMed
Google Scholar
Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB: Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab. 2006, 91 (3): 843-850.
Article
CAS
PubMed
Google Scholar
Traish AM, Saad F, Guay A: The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. J Andol. 2009, 30 (1): 23-32.
Article
CAS
Google Scholar
Dandona P, Dhindsa S, Chandel A, Chaudhuri A: Hypogonadotropic hypogonadism in men with type 2 diabetes. Postgrad Med. 2009, 121 (3): 45-51. 10.3810/pgm.2009.05.2001.
Article
PubMed
Google Scholar
Saad F, Gooren LJ: The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2. J Obes. 2011, 2011: 471584-
Article
PubMed
Google Scholar
Svartberg J, von Muhlen D, Sundsfjord J, Jorde R: Waist circumference and testosterone levels in community dwelling men. The Tromso study. Eur J Epidemiol. 2004, 19 (7): 657-663.
Article
CAS
PubMed
Google Scholar
Rosmond R, Wallerius S, Wanger P, Martin L, Holm G, Bjorntorp P: A 5-year follow-up study of disease incidence in men with an abnormal hormone pattern. J Intern Med. 2003, 254 (4): 386-390. 10.1046/j.1365-2796.2003.01205.x.
Article
CAS
PubMed
Google Scholar
Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB: Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care. 2000, 23 (4): 490-494. 10.2337/diacare.23.4.490.
Article
CAS
PubMed
Google Scholar
Selvin E, Feinleib M, Zhang L, Rohrmann S, Rifai N, Nelson WG, Dobs A, Basaria S, Golden SH, Platz EA: Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care. 2007, 30 (2): 234-238. 10.2337/dc06-1579.
Article
CAS
PubMed
Google Scholar
Yialamas MA, Dwyer AA, Hanley E, Lee H, Pitteloud N, Hayes FJ: Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2007, 92 (11): 4254-4259. 10.1210/jc.2007-0454.
Article
CAS
PubMed
Google Scholar
Basaria S: Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth. J Andol. 2008, 29 (5): 534-539. 10.2164/jandrol.108.005454.
Article
Google Scholar
Jones TH: Effects of testosterone on type 2 diabetes and components of the metabolic syndrome. J Diabetes. 2010, 2 (3): 146-156. 10.1111/j.1753-0407.2010.00085.x.
Article
CAS
PubMed
Google Scholar
Svartberg J, Agledahl I, Figenschau Y, Sildnes T, Waterloo K, Jorde R: Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip. Int J Impot Res. 2008, 20 (4): 378-387. 10.1038/ijir.2008.19.
Article
CAS
PubMed
Google Scholar
Boyanov MA, Boneva Z, Christov VG: Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male. 2003, 6 (1): 1-7.
Article
CAS
PubMed
Google Scholar
Marin P, Holmang S, Jonsson L, Sjostrom L, Kvist H, Holm G, Lindstedt G, Bjorntorp P: The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord. 1992, 16 (12): 991-997.
CAS
PubMed
Google Scholar
Haider A, Gooren LJ, Padungtod P, Saad F: Beneficial effects of 2 years of administration of parenteral testosterone undecanoate on the metabolic syndrome and on non-alcoholic liver steatosis and C-reactive protein. Horm Molec Biol Clin Invest. 2010, 1 (1): 27-33. 10.1515/HMBCI.2010.002.
CAS
Google Scholar
Pitteloud N, Hardin M, Dwyer AA, Valassi E, Yialamas M, Elahi D, Hayes FJ: Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab. 2005, 90 (5): 2636-2641. 10.1210/jc.2004-2190.
Article
CAS
PubMed
Google Scholar
Pitteloud N, Mootha VK, Dwyer AA, Hardin M, Lee H, Eriksson KF, Tripathy D, Yialamas M, Groop L, Elahi D, Hayes FJ: Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care. 2005, 28 (7): 1636-1642. 10.2337/diacare.28.7.1636.
Article
CAS
PubMed
Google Scholar
Rabiee A, Dwyer AA, Caronia LM, Hayes FJ, Yialamas MA, Andersen DK, Thomas B, Torriani M, Elahi D: Impact of acute biochemical castration on insulin sensitivity in healthy adult men. Endocr Res. 2010, 35 (2): 71-84. 10.3109/07435801003705601.
Article
CAS
PubMed
Google Scholar